Microba Life Sciences Limited

A$0.04As of Sun 8 Nov 2026, 12:00 UTC
ASX:MAPHealthcare
Country Australia
PE (Fwd) •••
TSR 5Y CAGR (39.10%)
Div yield —
ROE (72.87%)
Diagnostics & Research
Beta (5Y) 2.13
PE TTM —
TSR TTM (53.16%)
Mkt cap A$25.91M
ROIC (39.53%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0357
(3.47%)
(4.33%)
Sell 1|9|2|9|9
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
12.22%
14.72%
8.09%
7.85%
Revenue$M
3.584
3.632
3.802
3.944
12.38%
8.35%
14.13%
13.90%
Peers (US$17.80M)
Cap (US$)
PE
12.89M
99.65x
Capital
TTM
5Y
10Y
Leveragex
0.880
1.304
1.132
EBIT/Intx
1.208
0.324
0.287
Own earn%
(33.36)
(101.62)
(109.44)
Sh yield%
51.27
33.97
35.32
Owners
Insiders/Inst%
14.80
29.03
Short interest%
3.03
SBC / revenue%
1.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
26–33
$1 testx
—
Incr. ROIC%
5